The Allstate Corporation
NYSE:ALLInsurance - Property & Casualty
-$2.30 today
- Market cap
- $65.97B
- Beta
- 0.19
- P/E (TTM)
- 4.7
- EPS (TTM)
- $46.82
- Dividend yield
- 1.90%
Volume 1.38M
Average 1.52M
ALL Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
The Allstate CorporationNYSE: ALL
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 15.6% from a year ago
Cash & equivalents stood at $840M at the end of Q2 FY2026, down 15.6% from a year earlier and up 20.5% from the prior quarter. Over 3 fiscal years it compounded at -2.7% a year.
Context
- Cash & equivalents amounted to 0.7% of total assets at the end of Q2 FY2026, down 0.2 pp from a year earlier.
- Cash & equivalents increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -15.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 678M USD
- Year-over-year change
- -3.7%
- 4-year CAGR
- -2.9%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 678M | -3.7% |
| FY2024 | 2024-12-31 | 704M | -2.5% |
| FY2023 | 2023-12-31 | 722M | -1.9% |
| FY2022 | 2022-12-31 | 736M | -3.5% |
| FY2021 | 2021-12-31 | 763M | — |
Cash & Equivalents vs competitors
How ALL compares with its peers on the latest reported figures
- ALL's Jun 2026 cash & equivalents of $840M is the 3rd highest of the 11 companies compared; the peer median is $241.5M.
- Its year-over-year change of -15.6% is the 6th highest of 11, against a peer median of -16.6%.
- Cash & equivalents amounts to 0.7% of total assets for ALL, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $3.01B | +34.3% | +4.1% | 1.1% | |
| Sep 2026 | $1.24B | -15.1% | +4.2% | 2.9% | |
| Jun 2026 | $840M | -15.6% | -2.7% | 0.7% | |
| Sep 2026 | $766M | +29.4% | -3.9% | 0.5% | |
| Sep 2026 | $506.3M | -44.7% | +54.4% | 3.0% | |
| Sep 2026 | $360M | -25.5% | -3.6% | 0.5% | |
| Sep 2026 | $123M | -18.0% | -16.6% | 0.1% | |
| Mar 2026 | $54.83M | -15.3% | +42.9% | 2.3% | |
| Sep 2026 | $46.21M | -12.2% | +31.2% | 0.7% | |
| Sep 2026 | $928K | -96.2% | -10.7% | 0.0% | |
| Sep 2026 | $0 | -100.0% | -15.0% | 0.0% | |
| Peer median (excluding ALL) | $241.5M | -16.6% | +0.2% | 0.6% | |
Competitors are the stored peer set for ALL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 763M | 736M | 722M | 704M | 678M |
| Short-term Investments | 4.01B | 4.17B | 5.14B | 4.54B | 4.89B |
| Net Receivables | 18.39B | 18.78B | 18.85B | 19.54B | 20.68B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 23.16B | 23.69B | 24.72B | 24.78B | 26.25B |
| Property, Plant & Equipment (Net) | 939M | 987M | 859M | 669M | 627M |
| Goodwill | 3.5B | 3.5B | 3.5B | 3.25B | 3.12B |
| Intangible Assets | 1.42B | 1.18B | 966M | 754M | 6.72B |
| Long-term Investments | 4.01B | 3.94B | 3.24B | 4.72B | 78.35B |
| Tax Assets | 0 | 382M | 219M | 231M | 0 |
| Other Non-current Assets | 66.41B | 64.31B | 69.86B | 77.22B | 4.69B |
| Total Non-current Assets | 76.28B | 74.3B | 78.64B | 86.84B | 93.51B |
| Total Assets | 99.44B | 97.99B | 103.36B | 111.62B | 119.76B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 0 | 0 | 0 | 0 | 550M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 29.08B |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 41.31B |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 70.94B |
| Long-term Debt | 7.98B | 7.96B | 7.94B | 8.09B | 6.94B |
| Deferred Tax Liabilities | 833M | 0 | 0 | 0 | 227M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 65.5B | 72.66B | 77.79B | 82.17B | 11.07B |
| Total Non-current Liabilities | 74.31B | 80.63B | 85.73B | 90.25B | 18.23B |
| Total Liabilities | 74.31B | 80.63B | 85.73B | 90.25B | 89.17B |
| Common Stock | 9M | 9M | 9M | 9M | 9M |
| Retained Earnings | 53.29B | 50.97B | 49.72B | 53.29B | 62.39B |
| Accumulated OCI | 655M | (2.39B) | (700M) | (889M) | 255M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | (52M) | (125M) | (140M) | (75M) | (21M) |
| Total Equity | 25.13B | 17.36B | 17.63B | 21.37B | 30.59B |
| Total Debt | 7.98B | 7.96B | 7.94B | 8.09B | 7.49B |
| Net Debt | 7.21B | 7.23B | 7.22B | 7.38B | 6.81B |
The Allstate Corporation
NYSE:ALL
Intrinsic Alpha fair value
Locked
Current Price
$266.59
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.